SNUH-CD19-CAR-T / Seoul National University Hospital - LARVOL DELTA

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: Seoul National University Hospital

CAR T-Cell Therapy • New P2 trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Bone Marrow Transplantation • Hematological Malignancies • Leukemia • Oncology • Pediatrics • Transplantation

Advanced regenerative medicine committee decides on high-risk research related to acute lymphoblastic leukemia and knee osteoarthritis [Google translation] (Medifonews) - "The Ministry of Health and Welfare announced on the 22nd that it held the '2023 9th Advanced Regenerative Medicine and Advanced Biopharmaceutical Review Committee' on the 21st...This review committee reviewed a total of 6 advanced regenerative medicine clinical research projects...submitted by Seoul National University Hospital and Seoul St. Mary's Hospital of the Catholic University of Korea, and approved 2 cases as appropriate...The principal investigator announced that he plans to conduct treatment and research on 50 patients, and that the research cost will be approximately 6 billion won, which will be self-funded through donations...The second task is a clinical study to treat patients with knee osteoarthritis by administering induced pluripotent stem cell-derived chondrocyte aggregates (MIUChon) intraarticularly....The above two tasks are being reviewed by the review committee simultaneously undergoing approval review by the Ministry of Food and Drug Safety."

Clinical • New trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • CNS Disorders • Hematological Malignancies • Leukemia • Oncology • Osteoarthritis • Pain